secwatch.observer — SEC 8-K summary
======================================

Issuer:     vTv Therapeutics Inc. (VTVT)
CIK:        0001641489
Form:       8-K
Filed at:   2026-05-13T21:20:45+00:00
Accession:  0001193125-26-221971
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

vTv Therapeutics upsizes ATM program to maximum authorized shares
-----------------------------------------------------------------

- Filed a prospectus supplement to increase shares offered under its at-the-market sales program to the full amount authorized.
- The expanded ATM program is under the company's existing shelf registration statement on Form S-3.
- Legal opinion from Dechert LLP on share legality was filed as part of the registration update.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1641489/000119312526221971/0001193125-26-221971-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1641489/000119312526221971/d72453d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-221971

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer